Business Wire

IL-NIELSENIQ

24.7.2024 16:01:26 CEST | Business Wire | Press release

Share
NIQ Releases 2023 Environment, Social and Governance (ESG) Progress Report

NielsenIQ (NIQ), the world’s leading consumer intelligence company, has released its second Environmental, Social and Governance (ESG) Progress Report detailing the Company’s ESG priorities, how it embeds inclusive, sustainable principles into its business model and its commitment to delivering intelligence and innovation to customers that positively impact economies, communities, and the environment.

“Our ESG strategy is designed to drive long-term value — for our employees, our stakeholders, our customers, our industry, our vendors, and our communities,” said Jim Peck, Chief Executive Officer, NIQ. "We are focused on integrating our ESG priorities company-wide and increasing our impact. Additionally, by providing a thorough understanding of consumer purchasing behavior, we aim to offer market intelligence to our clients and their ecosystems to support their sustainability efforts."

Notable highlights in the 2023 ESG Report:

Data Integrity, Privacy & Security
Data is at the core of NIQ’s business. The company is focused on delivering secure and protected data with a high-level of precision and integrity.

  • Ensuring Data Integrity: NIQ takes measures to ensure that data is accurate and relevant. In the past year, NIQ has established a dedicated Generative AI taskforce that explores next-generation AI applications, with an emphasis on data quality, completeness, and ethical considerations. It also has established quality checks for field data collection, including having strict controls in place for field auditors to ensure high integrity and an incident response plan so that deviations from standard practices can immediately be addressed.
  • Fortifying and Securing NIQ’s Data: NIQ has robust practices to identify and address data security risks. To identify vulnerabilities, NIQ conducts regular vulnerability scanning and assessments of all information systems. To address them, NIQ has a cybersecurity team that implements multiple layers of organizational, technical, and administrative measures to protect data.
  • Prioritizing Data Privacy: NIQ follows a comprehensive set of privacy principles, which include user-friendly privacy controls, clear notice, and choice options. In addition to complying with laws and industry standards in the countries in which it operates, NIQ incorporates privacy safeguards directly into the design and implementation of NIQ products and services.
  • Safeguarding NIQ’s Digital Future. NIQ is prioritizing seamless security integration throughout the organization, focusing on its people, data privacy, and confidentiality. The ongoing Cybersecurity and Privacy Program unifies global departments, leveraging NIST CSF and ISO 27002 standards.

Environmental Responsibility

  • Pioneering Sustainable Impact. With a commitment to help shape marketplaces, NIQ collaborates with clients to encourage transition to more sustainable products by reflecting the evolving conscious consumer trends. In 2023, NIQ partnered with McKinsey & Company to develop a report titled “Consumers care about sustainability – and back it up with their wallets”.
  • NIQ has adopted a data driven approach to measuring carbon footprint, and measured carbon footprint for a second year in 2022.
  • NIQ works closely with vendors and partners to select energy-efficient lease properties and investigate opportunities to implement clean energy and energy-reduction initiatives.
  • NIQ has optimized its data centers to reduce energy use, with approximately 90% of NIQ’s servers being virtualized in 2022, resulting in significant energy savings.
  • For a decade, NIQ has provided Feeding America® with data, insights, and expertise, including local food pricing data to estimate meal costs in every U.S. County for Map the Meal Gap report. This report raises awareness of food insecurity across the U.S. and is used by food banks and policymakers.

People & Diversity, Equity, and Inclusion

  • Continuing to improve the diversity of its workforce. NIQ is committed to building a diverse workforce, equitable processes, and an inclusive culture aligned with its core values.
    • Minority group members now serve in 29% of roles across the organization and women serve in half of the workforce, with over 43% female representation in global leadership positions.
    • In 2023, NIQ renewed its LEAD Network Europe CEO Pledge to further accelerate gender parity and to prioritize gender equity.
  • Embracing Diversity, Equity, and Inclusion. As part of its integration efforts with GfK, NIQ has made a conscious effort to understand its unique company culture and to foster a combined environment that promotes inclusion in all areas of the company. NIQ has strongly encouraged cross-entity internal hiring, so associates can develop their careers and realize their aspirations, and as of August 2023, NIQ has posted more than 500 open roles for internal applicants in NIQ and GfK.
  • Extending People & Planet Day. During its second annual People & Planet Day, 13,000 global employees contributed to local volunteer efforts, participating in various activities. Overall, NIQ contributed over 75,000 hours, covering more than 500 activities, with nearly $67,000 in employee fundraising. This was a combined activity for legacy NIQ and legacy GfK associates.

“NIQ data can help companies and communities make informed decisions that ultimately help grow their business sustainably and support communities that they serve,” said John Blenke, Chief Legal Officer. “We are proud of our ESG efforts to date and look forward to scale our positive impact through continued progress.”

NIQ aligns ESG reporting with the UN Sustainable Development Goals and the Sustainability Accounting Standards Board (SASB) Standards for Professional Commercial Services. To learn more about NIQ’s approach to ESG, the company’s continued commitment to creating value for society and its progress on key goals, please visit the NIQ’s 2023 ESG Progress Report.

About NIQ

NielsenIQ (NIQ) is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together the two industry leaders with unparalleled global reach. Today NIQ has operations in more than 95 countries covering 97% of GDP. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240724714892/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye